Overview of interleukin-18:: more than an interferon-γ inducing factor

被引:327
作者
Dinarello, CA
Novick, D
Puren, AJ
Fantuzzi, G
Shapiro, L
Mühl, H
Yoon, DY
Reznikov, LL
Kim, SH
Rubinstein, M
机构
[1] Univ Colorado, Hlth Sci Ctr, Div Infect Dis, Denver, CO 80262 USA
[2] Weizmann Inst Sci, IL-76100 Rehovot, Israel
关键词
nuclear factor-kappa B; interleukin-1; beta;
D O I
10.1002/jlb.63.6.658
中图分类号
Q2 [细胞生物学];
学科分类号
071009 [细胞生物学]; 090102 [作物遗传育种];
摘要
Initially described in 1989 as interferon-gamma (IFN-gamma) inducing factor (IGIF), interleukin-18 (IL-18) is a novel pro-inflammatory-cytokine that is clearly more than an inducer of IFN-gamma, The cytokine possesses several biological properties such as activation of nuclear factor-kappa B (NF-kappa B), Fas ligand expression, the induction of both CC and CSC chemokines, and increased production of competent human immunodeficiency virus. Most activities are due to a receptor complex that recruits the IL-1 receptor-activating kinase (IRAK), leading to translocation of NF-kappa B, This property and others support the concept that IL-18 is related to the IL-1 family, Indeed, one of the 1L-18 receptor chains is the IL-1 receptor-related protein, a member of the IL-1R family. In addition, IL-18 is structurally similar to IL-1 beta and like IL-1 beta is first synthesized as a leaderless precursor requiring the IL-1 beta converting enzyme for cleavage into an active molecule. The biology of IL-18 is reviewed in the overview and the implication for a role for this cytokine in disease is presented.
引用
收藏
页码:658 / 664
页数:7
相关论文
共 62 条
[1]
Ahn HJ, 1997, J IMMUNOL, V159, P2125
[2]
Involvement of caspase-1 and caspase-3 in the production and processing of mature human interleukin 18 in monocytic THP.1 cells [J].
Akita, K ;
Ohtsuki, T ;
Nukada, Y ;
Tanimoto, T ;
Namba, M ;
Okura, T ;
TakakuraYamamoto, R ;
Torigoe, K ;
Gu, Y ;
Su, MSS ;
Fujii, M ;
SatohItoh, M ;
Yamamoto, K ;
Kohno, K ;
Ikeda, M ;
Kurimoto, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (42) :26595-26603
[3]
ALNEMRI ES, 1996, CELL, V87, P123
[4]
A newly defined interleukin-1? [J].
Bazan, JF ;
Timans, JC ;
Kastelein, RA .
NATURE, 1996, 379 (6566) :591-591
[5]
Bresnihan B., 1996, Arthritis and Rheumatism, V39, pS73
[6]
INTERFERON-GAMMA RECEPTOR-DEFICIENT MICE ARE RESISTANT TO ENDOTOXIC-SHOCK [J].
CAR, BD ;
ENG, VM ;
SCHNYDER, B ;
OZMEN, L ;
HUANG, S ;
GALLAY, P ;
HEUMANN, D ;
AGUET, M ;
RYFFEL, B .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (05) :1437-1444
[7]
Conti B, 1997, J BIOL CHEM, V272, P2035
[8]
NF-KAPPA-B ACTIVATION BY INTERLEUKIN-1 (IL-1) REQUIRES AN IL-1 RECEPTOR-ASSOCIATED PROTEIN-KINASE ACTIVITY [J].
CROSTON, GE ;
CAO, ZD ;
GOEDDEL, DV .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (28) :16514-16517
[9]
Interferon-gamma-inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper 1 cells [J].
Dao, T ;
Ohashi, K ;
Kayano, T ;
Kurimoto, M ;
Okamura, H .
CELLULAR IMMUNOLOGY, 1996, 173 (02) :230-235
[10]
Biologic basis for interleukin-1 in disease [J].
Dinarello, CA .
BLOOD, 1996, 87 (06) :2095-2147